End Stage Renal Disease Treatment Choices Learning Collaborative

Page tree

You are viewing an old version of this page. View the current version.

Compare with Current View Page History

« Previous Version 108 Next »








The End Stage Renal Disease Treatment Choices Learning Collaborative is a national quality improvement initiative that brings together HRSA, CMS, transplant centers, OPOs, donor hospitals, and donor and recipient patients and families to generate increased quality and cost-savings using systematic quality and process improvement.









News and Updates


NATIONAL AIMS

Over a 5 year period the End Stage Renal Disease Treatment Choices Learning Collaborative intends to achieve the following national aims:


Increase the number of deceased donor kidneys transplanted by 15%.

Decrease the current national discard rate of all procured kidneys by 5%.

Increase the utilization of high KDPI kidneys recovered (60-85 KDPI Score) by 14%.



Transplant Facts

Add facts here

Map data coming soon


Organ Procurement Organizations


 Transplant Centers


Donor Hospitals



National Faculty

Meet the National Faculty

National Faculty provide subject matter expertise to advise ETCLC participants throughout the improvement process. Led by two National Chairpersons, the eleven national faculty represent transplant nephrologists and surgeons, Organ Procurement Organization professionals, donor hospitals, data analysts and statisticians, and patients.

Leadership Coordinating Council

Meet the National Coordinating Council

The Leadership Coordinating Council is a group of 20 national stakeholders that guide the ETCLC.  Members represent the kidney community, hospitals, dialysis services, quality improvement, social work, and patients.

  • No labels